Maternal Screening Quality Control

Home - Quality Control - Maternal Screening Quality Control
Therapeutic Drug Quality Control

The Randox Acusera Maternal Screening quality control is the only commercially available control to cover all six analytes used during first and second trimester screening of Down’s syndrome and Spina Bifida. Assayed instrument specific target values and ranges are provided for AFP, β hCG, Inhibin A, PAPP-A, Total hCG and Unconjugated Estriol. The inclusion of Inhibin A and PAPP-A eliminates the need to purchase additional controls at extra expense.

Features & Benefits

  • Lyophilised for enhanced stability
  • 100% human serum
  • Assayed target values provided for 6 parameters
  • Suitable for double, triple and quad screens
  • Unconjugated Estriol present at clinically significant levels
  • Stable to expiry date at 2°C – 8°C
  • Reconstituted stability of 7 days at 2°C – 8°C
DescriptionSizeAnalytesCat No
Maternal Screening Control Level 13 x 1 ml6MSS5024
Maternal Screening Control Level 23 x 1 ml6MSS5025
Maternal Screening Control Level 33 x 1 ml6MSS5026


  • AFP
  • PAPP-A
  • Free Beta hCG
  • Total hCG
  • Inhibin A
  • Unconjugated Oestriol

    Laboratory Quality Control